Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis

Bibliography

• Marepally S, Boakye CH, Patel AR, et al. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques. Nanomedicine (Lond) 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Tan X, Feldman SR, Chang J, et al. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv 2012;9:1263-71
   PubMed Web of Science ®Google Scholar
• Bayliffe AI, Brigandi RA, Wilkins HJ, et al. Emerging therapeutic targets in psoriasis. Curr Opin Pharmacol 2004;4:306-10
   PubMed Web of Science ®Google Scholar
• Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007;445:866-73
   PubMed Web of Science ®Google Scholar
• Thielen AM, Laffitte E. Topical treatments for psoriasis in 2009. Rev Med Suisse 2009;5:876-81
   PubMedGoogle Scholar
• Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 2012;9:783-804
   PubMed Web of Science ®Google Scholar
• Mitra A, Wu Y. Topical delivery for the treatment of psoriasis. Expert Opin Drug Deliv 2010;7:977-92
   PubMed Web of Science ®Google Scholar
• Guenther L, Cambazard F, Van De Kerkhof P, et al. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double blind, vehicle controlled clinical trial. Br J Dermatol 2002;147:316-23
   PubMed Web of Science ®Google Scholar
• Saraceno R, Camplone G, D’Agostino M, et al. Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol®-gel) in the treatment of scalp psoriasis: results from a study in 885 patients. J Dermatolog Treat 2014;25:30-3
   PubMed Web of Science ®Google Scholar
• Kragballe K, Austad J, Barnes L, et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris. Br J Dermatol 2006;154:1155-60
   PubMed Web of Science ®Google Scholar
• Kaufmann R, Bibby A, Bissonnette R, et al. A new calcipotriol/betamethasone dipropionate formulation (DaivobetTM) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002;205:389-93
   PubMed Web of Science ®Google Scholar
• Andrews SN, Jeong E, Prausnitz MR. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res 2013;30:1099-109
   PubMed Web of Science ®Google Scholar
• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361:496-509
   PubMed Web of Science ®Google Scholar
• Su Y-H, Fang J-Y. Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin Drug Deliv 2008;5:235-49
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000;199:167-77
   PubMed Web of Science ®Google Scholar
• Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 2002;81:225-33
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012;9:497-508
   PubMed Web of Science ®Google Scholar
• Muller RH, Shegokar R, Keck C. 20 years of lipid nanoparticles (SLN & NLC): present state of development and industrial applications. Curr Drug Discov Technol 2011;8:207-27
   PubMedGoogle Scholar
• Nikolic S, Gohla S, Muller RH. Lipid nanoparticles: nanocarriers for more effective and safer photoprotective products. Expert Rev Dermatol 2011;6:501-7
   Google Scholar
• Sivaramakrishnan R, Nakamura C, Mehnert W, et al. Glucocorticoid entrapment into lipid carriers – characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004;97:493-502
   PubMed Web of Science ®Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 2010;401:93-102
   PubMed Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163-71
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, et al. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781-5
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110:296-306
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 2004;95:627-38
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, et al. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2008;70:633-40
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singla S, et al. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. Mol Pharmaceutics 2013;10:1958-63
   PubMed Web of Science ®Google Scholar
• N’Dri-Stempfer B, Navidi W, Guy R, et al. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharm Res 2009;26:316-28
   PubMed Web of Science ®Google Scholar
• Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies V: permeation through damaged skin. J Pharm Sci 1985;74:1062-6
   PubMed Web of Science ®Google Scholar
• Liu S, Jin M-N, Quan Y-S, et al. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur J Pharm Biopharm 2014;86:267-76
   PubMed Web of Science ®Google Scholar
• Pellett M, Roberts M, Hadgraft J. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm 1997;151:91-8
   Web of Science ®Google Scholar
• Alvarez-Román R, Naik A, Kalia YN, et al. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004;99:53-62
   PubMed Web of Science ®Google Scholar
• Lau WM, Ng KW, White AW, et al. Therapeutic and cytotoxic effects of the novel antipsoriasis codrug, naproxyl–dithranol, on HaCaT Cells. Mol Pharm 2011;8:2398-407
   PubMed Web of Science ®Google Scholar
• Bhatia A, Singh B, Wadhwa S, et al. Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model. Pharm Dev Technol 2014;19:160-3
   PubMed Web of Science ®Google Scholar
• Sebök B, Bonnekoh B, Kerenyi M, et al. Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis. Skin Pharmacol Appl Skin Physiol 2000;13:285-91
   PubMedGoogle Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 2010;12:263-71
   PubMed Web of Science ®Google Scholar
• Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011;8:1407-24
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 1996;18:349-78
   Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. Pharmaceutical Press; London: 2003
   Google Scholar
• Tang C, Yin C, Pei Y, et al. New superporous hydrogels composites based on aqueous Carbopol® solution (SPHCcs): synthesis, characterization and in vitro bioadhesive force studies. Eur Polym J 2005;41:557-62
   Web of Science ®Google Scholar
• Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012;9:429-41
   PubMed Web of Science ®Google Scholar
• Franz TJ, Parsell DA, Halualani RM, et al. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999;38:628-32
   PubMed Web of Science ®Google Scholar
• Bhatia G, Zhou Y, Banga AK. Adapalene microemulsion for transfollicular drug delivery. J Pharm Sci 2013;102:2622-31
   PubMed Web of Science ®Google Scholar
• Jain S, Mistry MA, Swarnakar NK. Enhanced dermal delivery of acyclovir using solid lipid nanoparticles. Drug Deliv Trans Res 2011;1:395-406
   PubMed Web of Science ®Google Scholar
• Michniak-Kohn BB, Wertz PW, Al-Khalili M, et al. Skin: physiology and penetration pathways. In: Delivery system handbook for personal care and cosmetic products. William Andrew Publishing; Norwich, NY: 2005. p. 77-100
   Google Scholar
• Primavera G, Berardesca E. Sensitive skin: mechanisms and diagnosis. Int J Cosmet Sci 2005;27:1-10
   PubMedGoogle Scholar
• Geilen CC, Bektas M, Wieder T, et al. The vitamin D3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes. FEBS Lett 1996;378:88-92
   PubMed Web of Science ®Google Scholar
• Zulfakar MH, Ong CM, Heard CM. The effects of betamethasone dipropionate and fish oil on HaCaT proliferation and apoptosis. Int J Pharm 2012;434:399-405
   PubMed Web of Science ®Google Scholar
• Akdeniz N, Yavuz I, Bilgili S, et al. Comparison of efficacy of narrow band UVB-Alone, combination of calcipotriol-narrow band UVB, and combination betamethasone-calcipotriol-narrow band UVB therapies in vitiligo. J Dermatolog Treat 2014;25:196-9
   PubMed Web of Science ®Google Scholar